Evidence map›Paper›PMID 35632405›Full record

ArticleVaccines2022

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2.

Robert Daniel Heinrich Markewitz, David Juhl, Daniela Pauli, Siegfried Görg, Ralf Junker, Jan Rupp, Sarah Engel, Katja Steinhagen, Victor Herbst, Dorinja Zapf and 9 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Emerging Pathogens: Novel and Well-Known Infectious Threats in Transfusion Medicine.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Robert Daniel Heinrich MarkewitzInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
David JuhlInstitute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany.
Daniela PauliInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Siegfried GörgInstitute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany.
Ralf JunkerInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Jan RuppDepartment of Infectious Diseases and Microbiology, University of Lübeck, 23538 Lübeck, Germany.
Sarah EngelDepartment of Anesthesiology and Intensive Care, University Hospital of Schleswig-Holstein Campus Lübeck, 23562 Lübeck, Germany.
Katja SteinhagenInstitute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany.
Victor HerbstInstitute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany.
Dorinja ZapfInstitute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany.ORCID 0000-0002-2449-0951
Christina KrügerInstitute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany.
Christian BrockmannInstitute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany.
Frank LeypoldtInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Justina DargvainieneInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Benjamin SchomburgInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Shahpour Reza SharifzadehInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Lukas Salek NejadInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Klaus-Peter WandingerInstitute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Malte ZiemannInstitute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany.ORCID 0000-0003-0919-0237
University Hospital Schleswig-Holstein · DEEuroimmun Medizinische Labordiagnostika (Germany) · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunogenicitySARS-CoV-2serologyvaccination

Identifiers

PMID35632405
PMCPMC9145236
OpenAlexW4224313992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.